FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 119 filers reported holding FATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,000 | -38.8% | 14,356 | +36.8% | 0.00% | – |
Q2 2023 | $49,000 | +19.5% | 10,493 | +47.6% | 0.00% | – |
Q1 2023 | $41,000 | -82.5% | 7,111 | -69.3% | 0.00% | – |
Q4 2022 | $234,000 | +127.2% | 23,132 | +405.6% | 0.00% | – |
Q3 2022 | $103,000 | +3.0% | 4,575 | +13.8% | 0.00% | – |
Q2 2022 | $100,000 | -76.9% | 4,019 | -64.0% | 0.00% | – |
Q1 2022 | $433,000 | -72.5% | 11,176 | -58.5% | 0.00% | – |
Q4 2021 | $1,577,000 | +149.1% | 26,948 | +152.6% | 0.00% | – |
Q3 2021 | $633,000 | -95.2% | 10,670 | -92.9% | 0.00% | -100.0% |
Q2 2021 | $13,060,000 | +362.0% | 150,488 | +338.7% | 0.00% | +200.0% |
Q1 2021 | $2,827,000 | +15605.6% | 34,303 | +17224.7% | 0.00% | – |
Q4 2020 | $18,000 | -48.6% | 198 | -77.4% | 0.00% | – |
Q3 2020 | $35,000 | +118.8% | 877 | +90.2% | 0.00% | – |
Q2 2020 | $16,000 | +166.7% | 461 | +64.1% | 0.00% | – |
Q1 2020 | $6,000 | -85.7% | 281 | -87.0% | 0.00% | – |
Q4 2019 | $42,000 | – | 2,163 | +35950.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 6 | -99.6% | 0.00% | – |
Q3 2018 | $24,000 | +2300.0% | 1,451 | +1365.7% | 0.00% | – |
Q2 2018 | $1,000 | – | 99 | +41.4% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 70 | -98.0% | 0.00% | – |
Q3 2017 | $14,000 | – | 3,425 | +56983.3% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 6 | -94.2% | 0.00% | – |
Q3 2015 | $1,000 | -66.7% | 103 | -74.4% | 0.00% | – |
Q2 2015 | $3,000 | – | 403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |